These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35111686)

  • 1. Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma.
    Parvathareddy SK; Siraj AK; Ahmed SO; DeVera F; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Oncol; 2021; 11():819824. PubMed ID: 35111686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.
    Zhong X; Lu Y; Yin X; Wang Q; Wang F; He Z
    Gland Surg; 2022 Feb; 11(2):378-388. PubMed ID: 35284301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
    PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study.
    Suman P; Wang CH; Abadin SS; Moo-Young TA; Prinz RA; Winchester DJ
    Surgery; 2016 Jan; 159(1):31-9. PubMed ID: 26435436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
    Liu LS; Liang J; Li JH; Liu X; Jiang L; Long JX; Jiang YM; Wei ZX
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1327-1338. PubMed ID: 27645473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
    Yan B; Hou Y; Chen D; He J; Jiang Y
    Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma.
    Yang P; Li J; Jing H; Chen Q; Song X; Qian L
    Int J Endocrinol; 2021; 2021():8270622. PubMed ID: 34819955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A LASSO-based model to predict central lymph node metastasis in preoperative patients with cN0 papillary thyroid cancer.
    Zhao F; Wang P; Yu C; Song X; Wang H; Fang J; Zhu C; Li Y
    Front Oncol; 2023; 13():1034047. PubMed ID: 36761950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.
    Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G
    Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682
    [No Abstract]   [Full Text] [Related]  

  • 15. Preferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.
    Said M; Fujimoto M; Franken C; Woo S; Vuong B; Haigh PI
    Perm J; 2016; 20(4):15-251. PubMed ID: 27723445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients.
    Medas F; Canu GL; Cappellacci F; Anedda G; Conzo G; Erdas E; Calò PG
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.
    Ma B; Wang Y; Yang S; Ji Q
    Int J Surg; 2016 Apr; 28():153-61. PubMed ID: 26944586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
    Gao X; Luo W; He L; Cheng J; Yang L
    Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients.
    Liang K; He L; Dong W; Zhang H
    Med Sci Monit; 2014 May; 20():807-11. PubMed ID: 24831428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.